Microtubule-stabilising drugs for therapy of Alzheimer’s disease and other neurodegenerative disorders with axonal transport impairments

Author： Trojanowski John Q Smith Amos B Huryn Donna Lee Virginia M-Y

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.5, 2005-05, pp. : 683-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tocopherol (Vitamin E) in Alzheimers Disease and Other Neurodegenerative Disorders

By Karen Berman Henry Brodaty

CNS Drugs, Vol. 18, Iss. 12, 2004-01 ,pp. : 807-825

Adis International

Access to resources Recommend Favorite

Tau protein as a therapeutic target in Alzheimer’s disease and other neurodegenerative disorders

By Larner A.J.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 10, 1999-10 ,pp. : 1359-1370

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer’s disease and other neurodegenerative disorders

By Castro A. Martinez A.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 10, 2000-10 ,pp. : 1519-1527

Informa Healthcare

Access to resources Recommend Favorite

The Multifunctional Anti-inflammatory Drugs Used in the Therapy of Alzheimer’s Disease

Current Medicinal Chemistry, Vol. 20, Iss. 20, 2013-07 ,pp. : 2583-2588

Bentham Science Publishers

Access to resources Recommend Favorite

Flavonoids in the Treatment of Alzheimer’s and Other Neurodegenerative Diseases

Current Medicinal Chemistry, Vol. 25, Iss. 27, 2018-08 ,pp. : 3228-3246

Bentham Science Publishers

Access to resources Recommend Favorite